Karkus Nominees Caution Quigley Shareholders Not to be Fooled by the Company's Latest...

Karkus Nominees Caution Quigley Shareholders Not to be Fooled by the Company's
Latest Announcement

WOODMERE, N.Y., May 19 /PRNewswire/ -- The Quigley Corporation (Nasdaq: QGLY)
announced yesterday that its Board was exploring various options, including
hiring an investment banker and exploring "strategic alternatives".

Ted Karkus, Mark Burnett, John DeShazo, Mark Frank, Louis Gleckel, MD, Mark
Leventhal, and James McCubbin ("the Shareholder Nominees") believe that the
recent announcement is an 11th hour attempt to obtain shareholder votes and is
further evidence of the need for a slate of new highly qualified directors to
protect the interests of all shareholders.

"Shareholders should ask why the incumbents released this announcement just
two days before the shareholder meeting," commented Mr. Karkus. "A
responsible Board should always be reviewing the Company's strategic
alternatives," he added.

Ask yourself if you want the same Board that managed the Darius/Innerlight
sale last year to execute any further "strategic alternatives". The
Darius/Innerlight division was sold for a mere $1 million just before it
turned around in early 2008. Please read our last press release which
summarizes some of the many facts that trouble us with that transaction.

And, finally, ask yourself why they didn't pursue these "strategic
alternatives" when the Company's OTC division had increasing sales and
increasing profits, instead of now, when the division is likely to be worth
significantly less, given declining sales, increasing losses and a weaker
environment for selling assets.

For more information on the actions by Quigley management that have
necessitated this proxy contest and the Federal Court's decision to reject
Quigley's claims against the Shareholder Nominees, shareholders should refer
to our previous press releases and the court order which are available at
www.shareholdermaterial.com/QGLY

VOTING INSTRUCTIONS:

Only your last vote counts. Simply find the control # on our light blue shaded
Voting Instruction Form. This is the voting form that has the Ted Karkus list
of Shareholder Nominees on it. Then call (800) 454-8683 or go to
www.proxyvote.com and input your control # when prompted. It is that simple to
vote or to change your vote.

For any questions or assistance regarding the voting instructions, please
call the Shareholder Nominees' proxy solicitor, The Altman Group, toll free at
(866) 796-7175.

Mr. Karkus welcomes all calls to discuss the Company and its future with all
shareholders. He is available at (516) 569-9999.

Important Additional Information
Ted Karkus, Mark Burnett, John DeShazo, Mark Frank, Louis Gleckel, MD, Mark
Leventhal and James McCubbin (the "Shareholder Nominees") filed a definitive
proxy statement with the Securities and Exchange Commission (the "SEC") on May
1, 2009 in connection with the 2009 Annual Meeting of Stockholders of The
Quigley Corporation. Stockholders are strongly advised to read the Shareholder
Nominees' proxy statement as it contains important information. Stockholders
may obtain an additional copy of the Shareholder Nominee's definitive proxy
statement and any other documents filed by them with the SEC for free at the
SEC's website at http://www.sec.gov Additionally, copies of the definitive
proxy statement are available for free at www.shareholdermaterial.com/qgly

SOURCE Ted Karkus

Ted Karkus, +1-516-569-9999; or Paul Schulman of The Altman Group, Inc., for
Ted Karkus, +1-201-806-2206